Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01989988
Other study ID # MSIRB2013003
Secondary ID MSIRB2013003
Status Active, not recruiting
Phase N/A
First received January 22, 2013
Last updated November 15, 2013
Start date January 2013
Est. completion date December 2015

Study information

Verified date November 2013
Source Min-Sheng General Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Interventional

Clinical Trial Summary

The investigators would like to conduct a randomized clinical trial to compare the efficacy of diabetes treatment between different gastric bypass procedures involving type 2 diabetics patients with BMI from 27.5 to 35 kg/m2


Description:

The investigators would like to conduct a randomized clinical trial to compare the efficacy of diabetes treatment between different gastric bypass procedures involving type 2 diabetics patients with BMI from 27.5 to 35 kg/m2. This program will determine the relative effectiveness among LMGB 、RYGB and SADJB .The primary end point including HbA1C<6.0%, LDL-C<100mg/dl and SBP<130mmHg at one year after surgery. Through this study, the investigators may understand which gastric bypass is the best for type 2 diabetic's treatment. The investigators also hope some new treatment modulation may be developed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date December 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 67 Years
Eligibility Inclusion Criteria:

- Age 20 to 67 years

- Diagnosed with T2DM at least 6 months prior to enrollment, under the active care of a doctor for at least the six months prior to enrollment, HbA1c = 7.5 %

- Body Mass Index (BMI) = 27.5 kg/m 2 and = 34.9 kg/m 2

- Willingness to accept random assignment to either treatment group.

- Willingness to comply with the follow-up protocol

- Written informed consent.

Exclusion Criteria:

- Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.

- Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.

- Cardiac stress test indicating that surgery would not be safe.

- Pulmonary embolus or thrombophlebitis in the past six months

- Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years

- Serum creatinine = 1.5 mg/dl

- History of stomach surgery, bile duct surgery, pancreatic surgery, splenectomy, or colon resection

- Previous organ transplantation.

- History of alcohol or drug dependency

- Current participation in a conflicting research protocol.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
LMGB

LRYGB

SADJB


Locations

Country Name City State
Taiwan Min-Sheng General Hospital Taoyuan City

Sponsors (1)

Lead Sponsor Collaborator
Min-Sheng General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Remission of diabetes remission of Diabetes Mellitus Type 2 after different types of Gastric bypass surgery two years Yes
Secondary weight loss and improvement in quality of life weight loss and improvements in quality of life after different types of gastric bypass surgery 2 years No
See also
  Status Clinical Trial Phase
Withdrawn NCT02668328 - Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients N/A
Completed NCT04314427 - Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS
Recruiting NCT05942079 - "The Effect of Reiki on Metabolic Parameters in Obese Type 2 Diabetes Patients''
Not yet recruiting NCT06333132 - Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat) N/A
Active, not recruiting NCT05579561 - Vegetarian Ketogenic Diet VS Omnivore Ketogenic Diet - Protocol of a Keto-vege Diet for Remission of Type 2 Diabetes N/A
Completed NCT02938026 - Changes of Diet, Physical Activity and Sleep Pattern and Their Effects on Glycemic and Weight Control in Hong Kong Chinese Obese Patients With Type 2 Diabetes After Bariatric Surgery Compared to Telephone Intensive Lifestyle Counselling N/A
Recruiting NCT05887271 - A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction Phase 2/Phase 3
Completed NCT02680873 - Efficacy of SASI Bypass for Type-2 Diabetic Obese Patients N/A
Completed NCT01364350 - TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
Not yet recruiting NCT05711043 - The GATE Trial: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device N/A
Completed NCT02784275 - A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes Phase 2
Recruiting NCT01874366 - Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187 Phase 1
Recruiting NCT03821636 - Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients. N/A
Recruiting NCT03904901 - Influence of Probiotics in Diabetic Cardiopathies With Excessive Weight N/A
Completed NCT02122874 - Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients Phase 3
Completed NCT03394157 - Randomized Comparative Study of Sleeve Gastrectomy Versus MGB and SASI Bypass , Randomized Study N/A
Recruiting NCT04227769 - IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes Phase 2
Active, not recruiting NCT05755321 - From Skin Fibroblasts to Neural Stem Cells to Investigate in Vitro the Impact of Diabetes on Adult Neurogenesis
Completed NCT04957589 - VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men N/A
Recruiting NCT05801614 - Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction N/A